Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
QuintilesIMS
Chubb
Cantor Fitzgerald
Covington
Teva
Medtronic
Daiichi Sankyo
Harvard Business School

Generated: December 12, 2017

DrugPatentWatch Database Preview

Metolazone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for metolazone and what is the scope of metolazone freedom to operate?

Metolazone
is the generic ingredient in four branded drugs marketed by Gd Searle Llc, Mylan, Roxane, Sandoz, Teva, Watson Labs, and Ucb Inc, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for metolazone. Eleven suppliers are listed for this compound.

Pharmacology for metolazone

Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis

Medical Subject Heading (MeSH) Categories for metolazone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MylanMETOLAZONEmetolazoneTABLET;ORAL076698-003Oct 19, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gd Searle LlcDIULOmetolazoneTABLET;ORAL018535-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozMETOLAZONEmetolazoneTABLET;ORAL076466-001Dec 19, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gd Searle LlcDIULOmetolazoneTABLET;ORAL018535-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaMETOLAZONEmetolazoneTABLET;ORAL075543-003Dec 24, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaMETOLAZONEmetolazoneTABLET;ORAL076833-001Mar 1, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ucb IncZAROXOLYNmetolazoneTABLET;ORAL017386-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Gd Searle LlcDIULOmetolazoneTABLET;ORAL018535-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsMETOLAZONEmetolazoneTABLET;ORAL076891-001Jul 21, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ucb IncZAROXOLYNmetolazoneTABLET;ORAL017386-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: metolazone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb IncMYKROXmetolazoneTABLET;ORAL019532-001Oct 30, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Argus Health
Farmers Insurance
Novartis
Fuji
Chubb
UBS
Cerilliant
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot